智通财经APP获悉,近日,IDEAYA Biosciences(IDYA.US)宣布,其发起的一项2期临床试验已完成首例患者的给药,该临床试验旨在评估darovasertib(IDE196)作为单一疗法用于原发性葡萄膜黑色素瘤(UM)患者的新辅助或辅助治疗的疗效,潜在的近期... 网页链接
IDEAYA Biosciences(IDYA.O)跌24%,公司拟增发价值高达8000万美元的股票。 网页链接
$IDEAYA生物科学(IDYA)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001610717-24-000367 Size: 10 KB 网页链接
$IDEAYA生物科学(IDYA)$ 8-K Current report, item 5.02 Accession Number: 0001193125-24-169573 Act: 34 Size: 142 KB 网页链接
$IDEAYA生物科学(IDYA)$ 8-K Current report, item 8.01 Accession Number: 0000950170-24-067644 Act: 34 Size: 169 KB 网页链接
$IDEAYA生物科学(IDYA)$ 8-K Current report, item 5.07 Accession Number: 0000950170-24-067407 Act: 34 Size: 188 KB 网页链接
$IDEAYA生物科学(IDYA)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001610717-24-000274 Size: 12 KB 网页链接
$IDEAYA生物科学(IDYA)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001610717-24-000275 Size: 12 KB 网页链接
$IDEAYA生物科学(IDYA)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001610717-24-000276 Size: 12 KB 网页链接
$IDEAYA生物科学(IDYA)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001610717-24-000278 Size: 12 KB 网页链接
$IDEAYA生物科学(IDYA)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001610717-24-000277 Size: 12 KB 网页链接
$IDEAYA生物科学(IDYA)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001610717-24-000279 Size: 12 KB 网页链接